{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:50:22Z","timestamp":1792716622122,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T00:00:00Z","timestamp":1524528000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12931-018-0783-2","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T11:01:59Z","timestamp":1524567719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation"],"prefix":"10.1186","volume":"19","author":[{"given":"Koichiro","family":"Kamio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arata","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniko","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Usuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Inomata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemi","family":"Morinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeru","family":"Kashiwada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Nishijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shioto","family":"Itakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nariaki","family":"Kokuho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Atsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyoshi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazue","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Gemma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,24]]},"reference":[{"key":"783_CR1","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788\u2013824.","journal-title":"Am J Respir Crit Care Med"},{"key":"783_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","volume":"183","author":"B Ley","year":"2011","unstructured":"Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183:431\u201340.","journal-title":"Am J Respir Crit Care Med"},{"key":"783_CR3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1159\/000087673","volume":"72","author":"RP Tabuena","year":"2005","unstructured":"Tabuena RP, Nagai S, Tsutsumi T, Handa T, Minoru T, Mikuniya T, et al. Cell profiles of bronchoalveolar lavage fluid as prognosticators of idiopathic pulmonary fibrosis\/usual interstitial pneumonia among Japanese patients. Respiration. 2005;72:490\u20138.","journal-title":"Respiration"},{"key":"783_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/mi.2008.85","volume":"2","author":"MS Wilson","year":"2009","unstructured":"Wilson MS, Wynn TA. Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol. 2009;2:103\u201321.","journal-title":"Mucosal Immunol"},{"key":"783_CR5","doi-asserted-by":"crossref","first-page":"780","DOI":"10.5858\/2010-0296-RA.1","volume":"135","author":"RJ Homer","year":"2011","unstructured":"Homer RJ, Elias JA, Lee CG, Herzog E. Modern concepts on the role of inflammation in pulmonary fibrosis. Arch Pathol Lab Med. 2011;135:780\u20138.","journal-title":"Arch Pathol Lab Med"},{"key":"783_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1165\/rcmb.2016-0121TR","volume":"55","author":"S Kolahian","year":"2016","unstructured":"Kolahian S, Fernandez IE, Eickelberg O, Hartl D. Immune mechanisms in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2016;55:309\u201322.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"783_CR7","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1016\/S0012-3692(15)52722-0","volume":"128","author":"SA Papiris","year":"2005","unstructured":"Papiris SA, Kollintza A, Kitsanta P, Kapotsis G, Karatza M, Milic-Emili J, et al. Relationship of BAL and lung tissue CD4+ and CD8+ T lymphocytes, and their ratio in idiopathic pulmonary fibrosis. Chest. 2005;128:2971\u20137.","journal-title":"Chest"},{"key":"783_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000097133","volume":"74","author":"ER Parra","year":"2007","unstructured":"Parra ER, Kairalla RA, Ribeiro de Carvalho CR, Eher E, Capelozzi VL. Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia. Respiration. 2007;74:159\u201369.","journal-title":"Respiration"},{"key":"783_CR9","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1164\/rccm.200812-1936OC","volume":"179","author":"I Kotsianidis","year":"2009","unstructured":"Kotsianidis I, Nakou E, Bouchliou I, Tzouvelekis A, Spanoudakis E, Steiropoulos P, et al. Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2009;179:1121\u201330.","journal-title":"Am J Respir Crit Care Med"},{"key":"783_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1189\/jlb.0707504","volume":"83","author":"IG Luzina","year":"2008","unstructured":"Luzina IG, Todd NW, Iacono AT, Atamas SP. Roles of T lymphocytes in pulmonary fibrosis. J Leukoc Biol. 2008;83:237\u201344.","journal-title":"J Leukoc Biol"},{"key":"783_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cyto.2013.12.003","volume":"66","author":"D Galati","year":"2014","unstructured":"Galati D, De Martino M, Trotta A, Rea G, Bruzzese D, Cicchitto G, et al. Peripheral depletion of NK cells and imbalance of the Treg\/Th17 axis in idiopathic pulmonary fibrosis patients. Cytokine. 2014;66:119\u201326.","journal-title":"Cytokine"},{"key":"783_CR12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.imbio.2012.05.020","volume":"218","author":"D Boveda-Ruiz","year":"2013","unstructured":"Boveda-Ruiz D, D\u2019Alessandro-Gabazza CN, Toda M, Takagi T, Naito M, Matsushima Y, et al. Differential role of regulatory T cells in early and late stages of pulmonary fibrosis. Immunobiology. 2013;218:245\u201354.","journal-title":"Immunobiology"},{"key":"783_CR13","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0022-3565(25)39287-6","volume":"243","author":"JH Harrison Jr","year":"1987","unstructured":"Harrison JH Jr, Lazo JS. High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis. J Pharmacol Exp Ther. 1987;243:1185\u201394.","journal-title":"J Pharmacol Exp Ther"},{"key":"783_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/019021499270114","volume":"25","author":"U Laxer","year":"1999","unstructured":"Laxer U, Lossos IS, Gillis S, Or R, Christensen TG, Goldstein RH, et al. The effect of enoxaparin on bleomycin-induced lung injury in mice. Exp Lung Res. 1999;25:531\u201341.","journal-title":"Exp Lung Res"},{"key":"783_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jcp.41.4.467","volume":"41","author":"T Ashcroft","year":"1988","unstructured":"Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988;41:467\u201370.","journal-title":"J Clin Pathol"},{"key":"783_CR16","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1172\/JCI36498","volume":"119","author":"FR D\u2019Alessio","year":"2009","unstructured":"D\u2019Alessio FR, Tsushima K, Aggarwal NR, West EE, Willett MH, Britos MF, et al. CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest. 2009;119:2898\u2013913.","journal-title":"J Clin Invest"},{"key":"783_CR17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/0003-9861(61)90291-0","volume":"93","author":"JF Woessner Jr","year":"1961","unstructured":"Woessner JF Jr. The determination of hydroxyproline in tissue and protein samples of this amino acid. Arch Biochem Biophys. 1961;93:440\u20137.","journal-title":"Arch Biochem Biophys"},{"key":"783_CR18","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1164\/rccm.200404-531OC","volume":"171","author":"Y Aono","year":"2005","unstructured":"Aono Y, Nishioka Y, Inayama M, Ugai M, Kishi J, Uehara H, et al. Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med. 2005;171:1279\u201385.","journal-title":"Am J Respir Crit Care Med"},{"key":"783_CR19","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1164\/ajrccm.156.6.9611057","volume":"156","author":"M Yaekashiwa","year":"1997","unstructured":"Yaekashiwa M, Nakayama S, Ohnuma K, Sakai T, Abe T, Satoh K, et al. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. Am J Respir Crit Care Med. 1997;156:1937\u201344.","journal-title":"Am J Respir Crit Care Med"},{"key":"783_CR20","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1189\/jlb.1012512","volume":"93","author":"ML Novak","year":"2013","unstructured":"Novak ML, Koh TJ. Macrophage phenotypes during tissue repair. J Leukoc Biol. 2013;93:875\u201381.","journal-title":"J Leukoc Biol"},{"key":"783_CR21","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1631\/jzus.B1700003","volume":"18","author":"YL Zhao","year":"2017","unstructured":"Zhao YL, Tian PX, Han F, Zheng J, Xia XX, Xue WJ, et al. Comparison of the characteristics of macrophages derived from murine spleen, peritoneal cavity, and bone marrow. J Zhejiang Univ Sci B. 2017;18:1055\u201363.","journal-title":"J Zhejiang Univ Sci B"},{"key":"783_CR22","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1369\/0022155413497366","volume":"61","author":"E Coffey","year":"2013","unstructured":"Coffey E, Newman DR, Sannes PL. Expression of fibroblast growth factor 9 in normal human lung and idiopathic pulmonary fibrosis. J Histochem Cytochem. 2013;61:671\u20139.","journal-title":"J Histochem Cytochem"},{"key":"783_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fphar.2014.00080","volume":"5","author":"X Peng","year":"2014","unstructured":"Peng X, Moore MW, Peng H, Sun H, Gan Y, Homer RJ, et al. CD4+CD25+FoxP3+ regulatory Tregs inhibit fibrocyte recruitment and fibrosis via suppression of FGF-9 production in the TGF-beta1 exposed murine lung. Front Pharmacol. 2014;5:80.","journal-title":"Front Pharmacol"},{"key":"783_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cyto.2015.07.005","volume":"76","author":"P Pandiyan","year":"2015","unstructured":"Pandiyan P, Zhu J. Origin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cells. Cytokine. 2015;76:13\u201324.","journal-title":"Cytokine"},{"key":"783_CR25","doi-asserted-by":"publisher","first-page":"L914","DOI":"10.1152\/ajplung.2000.278.5.L914","volume":"278","author":"T Arai","year":"2000","unstructured":"Arai T, Abe K, Matsuoka H, Yoshida M, Mori M, Goya S, et al. Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo. Am J Physiol Lung Cell Mol Physiol. 2000;278:L914\u201322.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"783_CR26","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1136\/thx.2005.056317","volume":"61","author":"K Nakagome","year":"2006","unstructured":"Nakagome K, Dohi M, Okunishi K, Tanaka R, Miyazaki J, Yamamoto K. In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-beta in the lung. Thorax. 2006;61:886\u201394.","journal-title":"Thorax"},{"key":"783_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.exphem.2005.10.008","volume":"34","author":"Y Ebihara","year":"2006","unstructured":"Ebihara Y, Masuya M, Larue AC, Fleming PA, Visconti RP, Minamiguchi H, et al. Hematopoietic origins of fibroblasts: II. In vitro studies of fibroblasts, CFU-F, and fibrocytes. Exp Hematol. 2006;34:219\u201329.","journal-title":"Exp Hematol"},{"key":"783_CR28","doi-asserted-by":"publisher","first-page":"7556","DOI":"10.4049\/jimmunol.166.12.7556","volume":"166","author":"R Abe","year":"2001","unstructured":"Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibroblasts: differentiation pathway and migration to wound sites. J Immunol. 2001;166:7556\u201362.","journal-title":"J Immunol"},{"key":"783_CR29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4049\/jimmunol.160.1.419","volume":"160","author":"J Chesney","year":"1998","unstructured":"Chesney J, Metz C, Stavitsky AB, Bacher M, Bucala R. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol. 1998;160:419\u201325.","journal-title":"J Immunol"},{"key":"783_CR30","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1164\/ajrccm.153.6.8665057","volume":"153","author":"J Zhu","year":"1996","unstructured":"Zhu J, Kaplan AM, Goud SN. Immunologic alterations in bleomycin-treated mice: role of pulmonary fibrosis in the modulation of immune responses. Am J Respir Crit Care Med. 1996;153:1924\u201330.","journal-title":"Am J Respir Crit Care Med"},{"key":"783_CR31","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/039463201002300207","volume":"23","author":"Y Shimizu","year":"2010","unstructured":"Shimizu Y, Dobashi K, Endou K, Ono A, Yanagitani N, Utsugi M, et al. Decreased interstitial FOXP3+ lymphocytes in usual interstitial pneumonia with discrepancy of CXCL12\/CXCR4 axis. Int J Immunopathol Pharmacol. 2010;23:449\u201361.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"783_CR32","doi-asserted-by":"publisher","first-page":"e15404","DOI":"10.1371\/journal.pone.0015404","volume":"5","author":"F Liu","year":"2010","unstructured":"Liu F, Liu J, Weng D, Chen Y, Song L, He Q, et al. CD4+CD25+Foxp3+ regulatory T cells depletion may attenuate the development of silica-induced lung fibrosis in mice. PLoS One. 2010;5:e15404.","journal-title":"PLoS One"},{"key":"783_CR33","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.ajpath.2016.03.020","volume":"186","author":"SZ Birjandi","year":"2016","unstructured":"Birjandi SZ, Palchevskiy V, Xue YY, Nunez S, Kern R, Weigt SS, et al. CD4+CD25hiFoxp3+ cells exacerbate bleomycin-induced pulmonary fibrosis. Am J Pathol. 2016;186:2008\u201320.","journal-title":"Am J Pathol"},{"key":"783_CR34","doi-asserted-by":"publisher","first-page":"L152","DOI":"10.1152\/ajplung.00313.2007","volume":"294","author":"BB Moore","year":"2008","unstructured":"Moore BB, Hogaboam CM. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2008;294:L152\u201360.","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"783_CR35","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1164\/ajrccm.163.7.9911068","volume":"163","author":"H Yasui","year":"2001","unstructured":"Yasui H, Gabazza EC, Tamaki S, Kobayashi T, Hataji O, Yuda H, et al. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse. Am J Respir Crit Care Med. 2001;163:1660\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"783_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/BF00201466","volume":"13","author":"KW Moore","year":"1991","unstructured":"Moore KW, Rousset F, Banchereau J. Evolving principles in immunopathology: interleukin 10 and its relationship to Epstein-Barr virus protein BCRF1. Springer Semin Immunopathol. 1991;13:157\u201366.","journal-title":"Springer Semin Immunopathol"},{"key":"783_CR37","doi-asserted-by":"publisher","first-page":"L341","DOI":"10.1152\/ajplung.00122.2010","volume":"300","author":"L Sun","year":"2011","unstructured":"Sun L, Louie MC, Vannella KM, Wilke CA, LeVine AM, Moore BB, et al. New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2\/CCR2 axis. Am J Physiol Lung Cell Mol Physiol. 2011;300:L341\u201353.","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"783_CR38","doi-asserted-by":"publisher","first-page":"e13242","DOI":"10.1371\/journal.pone.0013242","volume":"5","author":"E Garcia-Prieto","year":"2010","unstructured":"Garcia-Prieto E, Gonzalez-Lopez A, Cabrera S, Astudillo A, Gutierrez-Fernandez A, Fanjul-Fernandez M, et al. Resistance to bleomycin-induced lung fibrosis in MMP-8 deficient mice is mediated by interleukin-10. PLoS One. 2010;5:e13242.","journal-title":"PLoS One"},{"key":"783_CR39","doi-asserted-by":"publisher","first-page":"L280","DOI":"10.1152\/ajplung.00380.2004","volume":"289","author":"A Nakatani-Okuda","year":"2005","unstructured":"Nakatani-Okuda A, Ueda H, Kashiwamura S, Sekiyama A, Kubota A, Fujita Y, et al. Protection against bleomycin-induced lung injury by IL-18 in mice. Am J Physiol Lung Cell Mol Physiol. 2005;289:L280\u20137.","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"783_CR40","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/01902140902718205","volume":"35","author":"K Remund","year":"2009","unstructured":"Remund K, Rechsteiner T, Guo Z, Hofer M, Boehler A. Extracorporeal photopheresis in a rat model of pulmonary fibrosis. Exp Lung Res. 2009;35:359\u201370.","journal-title":"Exp Lung Res"},{"key":"783_CR41","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.immuni.2013.03.002","volume":"38","author":"N Ohkura","year":"2013","unstructured":"Ohkura N, Kitagawa Y, Sakaguchi S. Development and maintenance of regulatory T cells. Immunity. 2013;38:414\u201323.","journal-title":"Immunity"},{"key":"783_CR42","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1126\/science.1175202","volume":"325","author":"FK Swirski","year":"2009","unstructured":"Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009;325:612\u20136.","journal-title":"Science"},{"key":"783_CR43","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ejphar.2008.06.046","volume":"590","author":"H Oku","year":"2008","unstructured":"Oku H, Shimizu T, Kawabata T, Nagira M, Hikita I, Ueyama A, et al. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. Eur J Pharmacol. 2008;590:400\u20138.","journal-title":"Eur J Pharmacol"},{"key":"783_CR44","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1183\/09031936.00152106","volume":"29","author":"NI Chaudhary","year":"2007","unstructured":"Chaudhary NI, Roth GJ, Hilberg F, Muller-Quernheim J, Prasse A, Zissel G, et al. Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis. Eur Respir J. 2007;29:976\u201385.","journal-title":"Eur Respir J"},{"key":"783_CR45","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.cell.2015.08.021","volume":"162","author":"N Arpaia","year":"2015","unstructured":"Arpaia N, Green JA, Moltedo B, Arvey A, Hemmers S, Yuan S, et al. A distinct function of regulatory T cells in tissue protection. Cell. 2015;162:1078\u201389.","journal-title":"Cell"},{"key":"783_CR46","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1165\/rcmb.2017-0019OC","volume":"57","author":"CF Dial","year":"2017","unstructured":"Dial CF, Tune MK, Doerschuk CM, Mock JR. Foxp3+ regulatory T cell expression of keratinocyte growth factor enhances lung epithelial proliferation. Am J Respir Cell Mol Biol. 2017;57:162\u201373.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"783_CR47","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S2213-2600(17)30171-6","volume":"5","author":"DF McAuley","year":"2017","unstructured":"McAuley DF, Cross LM, Hamid U, Gardner E, Elborn JS, Cullen KM, et al. Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Respir Med. 2017;5:484\u201391.","journal-title":"Lancet Respir Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-018-0783-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-018-0783-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-018-0783-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T22:15:46Z","timestamp":1751580946000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-018-0783-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,24]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["783"],"URL":"https:\/\/doi.org\/10.1186\/s12931-018-0783-2","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,24]]},"assertion":[{"value":"4 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experimental protocols were approved by the animal care and use committee of Nippon Medical School (Tokyo, Japan).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Azuma A. and Gemma A. acquired personal fees from Nippon Kayaku Co., Tokyo, Japan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"71"}}